Long COVID is a new disease, and can present in a lot of different ways - but the lack of a consensus definition has led to patients being met with skepticism, delays in care and difficulty in obtaining the support they need. A newly published definition for #LongCOVID, written and published recently by The National Academies of Sciences, Engineering, and Medicine committee, might help get patients the care they require. Learn more: https://lnkd.in/ef6xREvA
Moderna
Biotechnology Research
Cambridge, Massachusetts 605,745 followers
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
About us
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
- Website
-
https://www.modernatx.com/?tc=soc_7y8qkt&cc=1004
External link for Moderna
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- Biotechnology and mRNA Therapeutics
Locations
-
Primary
200 Technology Sq
Cambridge, Massachusetts 02139, US
-
1 Upland Rd
Norwood, Massachusetts 02062, US
Employees at Moderna
-
Jean-Christophe Wüthrich
Business Technology Management | Strategic Planning & IT Governance | Service Management, Integration & Performance | Change Management | Sourcing…
-
Shawn Lipstein
Innovative UX Leader | Critical Design Thinker | Strategic Visionary | Empathetic Manager | Driven Partner | Crystal Clear Communicator
-
Lukasz Wielochowski
Head of Moderna Enterprise Solution Hub in Poland
-
Karen Doolittle
Associate Director, Pharmacovigilance Operations - Project Management (PgMP/PMP)
Updates
-
Last week, we partnered with Washington Post Live on an event titled, “Long COVID: Where Things Stand,” which spotlighted the causes, prevalence and long-term impacts of #LongCOVID on communities and the workforce four years since the start of the global COVID-19 pandemic. The event brought together top researchers, government leaders, advocates, and patients to discuss the latest research on Long COVID, its prevalence, and its wide-ranging impact on businesses, the economy, and the lives of millions of Americans. Watch highlights of the event below, and read more about the event: https://lnkd.in/e64ijqAj
-
In our latest #IRInsights video, our Chief Financial Officer Jamey Mock sat down to provide more insight into our financial performance, challenging market dynamics, and our focus for the second half of the year. Watch the full video: https://lnkd.in/e84cxvkx
-
Today, we reported financial results and provided business updates for the second quarter of 2024. Read more: https://lnkd.in/ewNUpyZv
-
📣 We're thrilled to share that we made the first shipment of our RSV vaccine yesterday! A monumental moment for Moderna, this marks our evolution into a multi-product company, and is a testament to #TeamModerna's incredible dedication and unwavering commitment to patients.
-
In every age group, even a mild #COVID19 infection may trigger a lasting set of problems – but for some people with certain risk factors — age, pregnancy, chronic conditions or a compromised immune system — an infection may bring serious illness. Here's what you need to know about vaccination against COVID-19 this fall: https://lnkd.in/ekS3KNHS
Long Covid and Vaccination: What You Need to Know
https://www.nytimes.com
-
Respiratory syncytial virus, or RSV, is a highly contagious seasonal respiratory virus and a leading cause of lower respiratory tract infections, causing between 6,000 to 10,000 deaths each year amongst adults 65 years and older in the United States. Learn more about RSV, how you can help prevent it's spread, and new recommendations for RSV vaccinations from the CDC’s Advisory Committee on Immunization Practices: https://lnkd.in/eghWfM5c
-
📢 This week we sponsored a Washington Post Live event focusing on the public health challenge of #LongCOVID. This crucial conversation brought together policymakers, medical researchers, and patients to explore the causes, prevalence, and long-term impacts of this condition. Thank you to Dr. Ziyad Al-Aly, Dr. Linda Sprague Martinez, Jaime Seltzer, Chimére L. Sweeney, Dr. Ashwin Vasan, and Rachel Beale for their invaluable contributions and commitment to understanding and combatting Long COVID. Together, we can make a difference!
-
Long COVID presents a growing public health challenge worldwide, and is having a major impact on the productivity of health systems and the wider workforce - with severe cases potentially costing the economy $200 billion in lost annual wages in the US alone. Join leading policymakers, medical researchers and patient advocates tomorrow at 9:00 am ET for a live conversation about the causes, prevalence and long-term impacts of #LongCOVID ⬇ https://lnkd.in/eiRcjSXN
The looming public health challenge of long covid
washingtonpost.com
-
A large new study in The New England Journal of Medicine shows that among people in the U.S. infected during the first two years of the pandemic, the percentage of vaccinated individuals who developed #LongCOVID was significantly lower than that of unvaccinated individuals. This study provides some of the strongest evidence yet that #vaccines reduce the risk of developing Long COVID. Learn more: https://lnkd.in/d25Pdp-2
Vaccines Significantly Reduce the Risk of Long Covid, Study Finds
https://www.nytimes.com